2006 - Fellow of the American Association for the Advancement of Science (AAAS)
A. Douglas Kinghorn spends much of his time researching Stereochemistry, Biochemistry, Pharmacognosy, Traditional medicine and Biological activity. His research integrates issues of Aglaia and Epidermoid carcinoma in his study of Stereochemistry. A. Douglas Kinghorn has researched Biochemistry in several fields, including Betulinic acid, Pharmacology and Garcinia mangostana.
The various areas that A. Douglas Kinghorn examines in his Pharmacognosy study include Flavonoid, Phenols, Terpenoid, Cytotoxicity and Anticarcinogen. In Anticarcinogen, A. Douglas Kinghorn works on issues like Antimutagen, which are connected to Quercetin, Piceid, Carcinogen and Piceatannol. His Traditional medicine research integrates issues from DPPH and Antioxidant.
The scientist’s investigation covers issues in Stereochemistry, Biochemistry, Pharmacognosy, Traditional medicine and Biological activity. His Stereochemistry research is multidisciplinary, relying on both Triterpene and Cytotoxicity. His Cytotoxicity research includes elements of Cytotoxic T cell and Pharmacology.
His Biochemistry study incorporates themes from Fractionation and Bioassay. A. Douglas Kinghorn interconnects Bark and Flavonoid in the investigation of issues within Pharmacognosy. His work on Traditional medicine is being expanded to include thematically relevant topics such as Botany.
A. Douglas Kinghorn mostly deals with Stereochemistry, Cytotoxicity, Apoptosis, Cytotoxic T cell and Natural. The Stereochemistry study combines topics in areas such as Cell culture and Lichen. His biological study spans a wide range of topics, including IC50, Absolute configuration, Pharmacology and Lactone.
His Apoptosis research is multidisciplinary, incorporating perspectives in Molecular biology, Cancer research, In vitro and Pathology. The subject of his Cytotoxic T cell research is within the realm of Biochemistry. His study in the fields of Terpenoid, Structure–activity relationship and Natural Product Research under the domain of Biochemistry overlaps with other disciplines such as Protein Phosphatase Inhibitor.
His primary scientific interests are in Cytotoxicity, Pharmacology, Cell growth, In vitro and Structure–activity relationship. His Cytotoxicity research is classified as research in Biochemistry. Biochemistry is often connected to Syzygium in his work.
His work in Pharmacology addresses subjects such as Streblus asper, which are connected to disciplines such as Glycoside and Biological activity. His study looks at the relationship between Cell growth and topics such as Pathology, which overlap with Protein kinase B, Cancer research and PI3K/AKT/mTOR pathway. His In vitro study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
Meishiang Jang;Lining Cai;George O. Udeani;Karla V. Slowing.
Drug discovery from medicinal plants.
Marcy J. Balunas;A. Douglas Kinghorn.
Life Sciences (2005)
IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene
Ahti Anttila;Ramesh V. Bhat;James A. Bond;Susan J. Borghoff.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2002)
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
Emily Pisha;Heebyung Chai;Ik Soo Lee;Tangai E. Chagwedera.
Nature Medicine (1995)
Drug discovery from natural sources.
Young-Won Chin;Marcy J. Balunas;Marcy J. Balunas;Hee Byung Chai;A. Douglas Kinghorn.
Aaps Journal (2006)
Antioxidant Xanthones from the Pericarp of Garcinia mangostana (Mangosteen)
Hyun-Ah Jung;Bao-Ning Su;William J. Keller;Rajendra G. Mehta.
Journal of Agricultural and Food Chemistry (2006)
Human Medicinal Agents from Plants
A. Douglas Kinghorn;Manuel F. Balandrin.
Human medicinal agents from plants. (1993)
Extraction of plant secondary metabolites.
William P. Jones;A. Douglas Kinghorn.
Methods of Molecular Biology (2012)
The relevance of higher plants in lead compound discovery programs.
A. Douglas Kinghorn;Li Pan;Joshua N. Fletcher;Heebyung Chai.
Journal of Natural Products (2011)
Chemical Constituents of the Fruits of Morinda citrifolia (Noni) and Their Antioxidant Activity
Bao Ning Su;Alison D. Pawlus;Alison D. Pawlus;Hyun Ah Jung;William J. Keller.
Journal of Natural Products (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: